Science Explorer Interactive view Map
Company · Montreal · Canada

Bristol-Myers Squibb (Canada)

Research works
86
▲ 18% vs 2013–17
Citations
1.5k
17.1 per fractional work
Top-10% rate
9.2%
record average 16.5%
Open access
25%
world 28%

Not ranked overall: Bristol-Myers Squibb (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.58× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.49× its world share, 0 worksBiochemistry, Geneti…Environmental Science: 0.74× its world share, 0 worksEnvironmental ScienceHealth Professions: 1.56× its world share, 0 worksHealth ProfessionsMedicine: 3.37× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 10.26× its world share, 1 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 10.3×. Every wedge is a field page.

Which keywords describe research at Bristol-Myers Squibb (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Synthesis, Enantioselective Synthesis, Chemotherapy, Biological Evaluation, Anticancer Agents, Parastomal Hernia and Stoma Complications.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life10▲ 8.5×8 topics
  2. Synthesis8▲ 17×12 topics
  3. Chemotherapy5▲ 8.5×13 topics
  4. Enantioselective Synthesis5▲ 37×3 topics
  5. Biological Evaluation5▲ 48×6 topics
  6. Anticancer Agents4▲ 20×4 topics
  7. Parastomal Hernia4▲ 467×1 topic
  8. Stoma Complications4▲ 467×1 topic
  9. Medicinal Chemistry4▲ 11×5 topics
  10. Asymmetric Catalysis3▲ 61×1 topic
  11. Stereocontrolled Synthesis3▲ 613×1 topic
  12. Asymmetric Synthesis3▲ 25×3 topics
  13. Transition Metal Catalysis3▲ 26×3 topics
  14. Clinical Trials3▲ 5.7×6 topics
  15. Targeted Therapy3▲ 15×4 topics
  16. Antiretroviral Therapy3▲ 14×5 topics
  17. C-C Bond Formation3▲ 35×2 topics
  18. Clinical Practice Guidelines2▲ 5.2×8 topics
  19. Cost-effectiveness Analysis2▲ 38×1 topic
  20. Health Utility Measures2▲ 38×1 topic
  21. Drug Discovery2▲ 6.8×6 topics
  22. Drug Resistance2▲ 8.5×5 topics
  23. Enantioselective Reactions2▲ 28×1 topic
  24. Organocatalysis2▲ 38×1 topic
  25. Prognostic Factors2▲ 5.7×5 topics
  26. Treatment Guidelines2▲ 12×3 topics
  27. Antimicrobial Resistance2▲ 9.4×3 topics
  28. Tumor Microenvironment2▲ 6.8×4 topics
  29. Amination2▲ 82×1 topic
  30. Catalytic2▲ 16×1 topic
  31. Organometallic Chemistry2▲ 16×3 topics
  32. HIV Infection2▲ 18×3 topics
  33. Hepatotoxicity2▲ 30×2 topics
  34. Metal-Catalyzed Reactions2▲ 23×2 topics
  35. Genomic Profiling2▲ 20×2 topics
  36. Neurotoxicity2▲ 11×2 topics
  37. ALK Inhibitors2▲ 34×1 topic
  38. Chemotherapy-Induced Peripheral Neuropathy2▲ 37×1 topic
  39. EGFR Mutations2▲ 34×1 topic
  40. Taxanes2▲ 37×1 topic

Which research topics does Bristol-Myers Squibb (Canada) publish most on?

By volume in 2022–2025: Cardiomyopathy and Myosin Studies, Health Systems, Economic Evaluations, Quality of Life, Cardiovascular Function and Risk Factors and Economic and Financial Impacts of Cancer.

  1. 1 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 1 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  3. 3 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  5. 5 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  8. 8 Systemic Lupus Erythematosus Research Rheumatology 0 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  10. 10 Primary Care and Health Outcomes General Health Professions 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.8%not open75.2%

World: 28% of research is openly available.

with international co-authors35.2%domestic only64.8%

World: 19% is written across borders.

How has Bristol-Myers Squibb (Canada)'s research output changed?

Output in 2018–2022 was 18% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Montreal

All research institutions in Montreal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.